These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

611 related items for PubMed ID: 18335382

  • 1. [Predictive value of NT-pro-BNP for the non-cardiologist. A study on 573 hospitalized patients with cardiovascular disease].
    Pfister R, Tan D, Thekkanal J, Erdmann E, Schneider CA.
    Dtsch Med Wochenschr; 2008 Mar; 133(12):564-9. PubMed ID: 18335382
    [Abstract] [Full Text] [Related]

  • 2. Influence of renal function on the usefulness of N-terminal pro-B-type natriuretic peptide as a prognostic cardiac risk marker in patients undergoing noncardiac vascular surgery.
    Goei D, Schouten O, Boersma E, Welten GM, Dunkelgrun M, Lindemans J, van Gestel YR, Hoeks SE, Bax JJ, Poldermans D.
    Am J Cardiol; 2008 Jan 01; 101(1):122-6. PubMed ID: 18157978
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. N-terminal prohormone brain natriuretic peptide as a marker for detecting low functional class patients and candidates for cardiac transplantation: linear correlation with exercise tolerance.
    Kallistratos MS, Dritsas A, Laoutaris ID, Cokkinos DV.
    J Heart Lung Transplant; 2007 May 01; 26(5):516-21. PubMed ID: 17449423
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of usefulness of N-terminal pro-brain natriuretic peptide as an independent predictor of cardiac function among admission cardiac serum biomarkers in patients with anterior wall versus nonanterior wall ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Haeck JD, Verouden NJ, Kuijt WJ, Koch KT, Van Straalen JP, Fischer J, Groenink M, Bilodeau L, Tijssen JG, Krucoff MW, De Winter RJ.
    Am J Cardiol; 2010 Apr 15; 105(8):1065-9. PubMed ID: 20381654
    [Abstract] [Full Text] [Related]

  • 9. Natriuretic peptides in patients with atrial fibrillation and advanced chronic heart failure: determinants and prognostic value of (NT-)ANP and (NT-pro)BNP.
    Rienstra M, Van Gelder IC, Van den Berg MP, Boomsma F, Van Veldhuisen DJ.
    Europace; 2006 Jul 15; 8(7):482-7. PubMed ID: 16798760
    [Abstract] [Full Text] [Related]

  • 10. Usefulness of repeated N-terminal pro-B-type natriuretic peptide measurements as incremental predictor for long-term cardiovascular outcome after vascular surgery.
    Goei D, van Kuijk JP, Flu WJ, Hoeks SE, Chonchol M, Verhagen HJ, Bax JJ, Poldermans D.
    Am J Cardiol; 2011 Feb 15; 107(4):609-14. PubMed ID: 21185000
    [Abstract] [Full Text] [Related]

  • 11. Association of plasma N-terminal pro-B-type natriuretic peptide with postoperative cardiac events in patients undergoing surgery for abdominal aortic aneurysm or leg bypass.
    Feringa HH, Bax JJ, Elhendy A, de Jonge R, Lindemans J, Schouten O, van den Meiracker AH, Boersma E, Schinkel AF, Kertai MD, van Sambeek MR, Poldermans D.
    Am J Cardiol; 2006 Jul 01; 98(1):111-5. PubMed ID: 16784932
    [Abstract] [Full Text] [Related]

  • 12. Relation of N-terminal pro-B-type natriuretic peptide to symptoms, severity, and left ventricular remodeling in patients with organic mitral regurgitation.
    Potocki M, Mair J, Weber M, Hamm C, Burkard T, Hiemetzberger R, Peters K, Jander N, Cron TA, Hess N, Hoffmann A, Gekeler H, Gohlke-Bärwolf C, Buser P, Mueller C.
    Am J Cardiol; 2009 Aug 15; 104(4):559-64. PubMed ID: 19660612
    [Abstract] [Full Text] [Related]

  • 13. N-terminal pro-B-type natriuretic peptide and long-term mortality in stable coronary heart disease.
    Kragelund C, Grønning B, Køber L, Hildebrandt P, Steffensen R.
    N Engl J Med; 2005 Feb 17; 352(7):666-75. PubMed ID: 15716560
    [Abstract] [Full Text] [Related]

  • 14. N-terminal pro-B-type natriuretic peptide is an independent predictor of outcome in an unselected cohort of critically ill patients.
    Meyer B, Huelsmann M, Wexberg P, Delle Karth G, Berger R, Moertl D, Szekeres T, Pacher R, Heinz G.
    Crit Care Med; 2007 Oct 17; 35(10):2268-73. PubMed ID: 17717488
    [Abstract] [Full Text] [Related]

  • 15. Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
    Grewal J, McKelvie RS, Persson H, Tait P, Carlsson J, Swedberg K, Ostergren J, Lonn E.
    Am J Cardiol; 2008 Sep 15; 102(6):733-7. PubMed ID: 18773998
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. N-terminal pro-brain natriuretic peptide: an independent risk predictor of cardiovascular congestion, mortality, and adverse cardiovascular outcomes in chronic peritoneal dialysis patients.
    Wang AY, Lam CW, Yu CM, Wang M, Chan IH, Zhang Y, Lui SF, Sanderson JE.
    J Am Soc Nephrol; 2007 Jan 15; 18(1):321-30. PubMed ID: 17167121
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. NT-pro-BNP for diagnostic and prognostic evaluation in patients hospitalized for syncope.
    Pfister R, Hagemeister J, Esser S, Hellmich M, Erdmann E, Schneider CA.
    Int J Cardiol; 2012 Mar 08; 155(2):268-72. PubMed ID: 21056483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.